Expression and significance of the protein and mRNA of metastasis suppressor gene Me491/cd63 and integrin a5 in ovarian cancer tissues

Purpose: To investigate the expression and significance of the proteins and mRNA of metastasis suppressor gene Me491/cd63 and integrin alpha5 in ovarian cancer tissues. Methods: RT-PCR and in situ hybridization were used to detect the expression of the proteins and mRNA of ME491/CD63 and integrin alpha5 in normal ovarian tissues (Group I), ovarian benign tumor tissues (Group II), ovarian borderline tumor tissues (Group III) and ovarian cancer tissues (Group IV), and the correlation between the expression and the age of patient, degree of differentiation, lymphatic metastasis, stage and pathological type was analyzed. Results: There was a significant change in gene expression between the well and moderately differentiated tumors and poorly differentiated tumors. Gene expression in Groups III and IV was significantly weak, and significantly different from that in Group II and the early-stages of Groups III and IV. There was a significant difference in gene expression between each group. Conclusion: There is low expression of the proteins and mRNA of ME491/CD63 and integrin alpha5 in ovarian cancer. The lower the pathological differentiation is, the more significant the loss of expression is and the more likely metastasis is.

Ovarian cancer; ME491/CD63; lntegrin a5; Metastasis

[1] He B., Liu L., Cook G.A. et al.: "Tetraspanin CD82 attenuates eellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion". J. Biol. Chem., 2005, 280, 3346.

[2] Zhou B., Liu L., Reddivari M. et al.: "T he palmitoylation of metastasis suppressor KAI1/CD82 is important for its motilityand invasiveness-inhibitory activity". Cancer Res., 2004, 64, 7455.

[3] Farhadieh R.D., Smee R., Ow K. et al.: "Down-regulation of KAII/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival". Cancer, Lett., 2004, 213, 91.

[4] Schiller J.H., Bittner G.: "Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an α5β/1-integrinfibronectin interaction". Cancer Res., 1995, 55, 6215.

[5] Hashida H., Takabayashi A., Tokuhara T. et al.: "Clinical significance of transmembrane 4 superfamily in colon cancer". Br. J. Cancer, 2003, 89, 158.

[6] Hemler M.E., Mannion B.A., Berditchevski F.: "Association of TM4SF proteins with integrins : relevance to cancer". Biochim. Biophys. Acta, 1996, 128, 67.

[7] Berditchevsk:i F., Zutter M.M., Hemler M.E.: "Characterization of novel complexes on the cell urface between integrins and proteins with 4 transmembrane domains". Mol. Biol. Cell, 1996, 7, 193.

[8] Kurose K., Zhou X.P., Araki T. et al.: "Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin DI expression, in primary epithelial ovarian carcinomas". Am. J. Pathol., 2001, 158, 2097.

[9] Jackson P., Millar D., Kingsley E. et al.: "Methylation of a CpG island within the promoter region of the KALL metastasis suppressor gene is not responsible for down-regulation of Kail expression in invasive cancers or cancer cell lines". Cancer Lett., 2000, 157, 169.

[10] Mashimo T., Bandyopadhyay S., Goodarzi G. et al.: "Activation of the tumor metastasis suppressor gene, Kail, by etoposide is mediated by p53 and c-Jun genes". Biochem. Biophys. Res. Commun., 2000, 274, 370.

[11] Duriez C., Falette N., Cortes U. et al.: "Absence of p53-dependent induction of metastatic suppressor Kail gene after DNA damage". Oncogene, 2000, 19, 2461.

[12] Jiang B., ZhangY., Zhou D.: "C ommon test methods in molecular biology". Beijing: People's Military Surgeon Publishing House, 1996, 128.